report strong rebas hif
report adj ep includ amort
kindred-at-hom vs opco/street estim result
driven retail segment adjust earn opco
driven moder util mild flu season howev group/specialti
earn opco weak due shift aso post-quart
rais adj ep guidanc
caution due return hif would like come
normal ep growth rais ep
lower estim price
target
guidanc rais adj ep guidanc
manag attribut increas retail
off-set retail earn rais vs
includ strong membership slightli lower ber
bp also said ep would low
full-year well ahead street prior
hif remain like headwind assum hif delay
next year manag expect ep growth long-term growth
rate target tax impact fee would repres
headwind note ep growth project due
tailwind fee
comment pharmaci although believ industri would benefit
certainti around rebat rule compani continu bid
part current law especi given protect risk-corridor
program would implement howev group busi would see
higher premium risk-corridor protect would applic
medicaid busi organ opportun stress effort
grow medicaid busi remain organ strategi compani highlight
particip texa louisiana rfp appear quash
suggest compani would look grow busi via acquisit
conclus compani exposur attract medicar market
relat util remain moder appear well-posit
beyond given signific pullback stock maintain
year price histori
multi-region health plan
provid full array product
employ group government-
sponsor plan individu
analyst certif import disclosur see disclosur
repeal health insur fee
reimburs news favor
believ boast compel growth opportun
increasingli appeal market buoy gop
support furthermor compani also opportun
drive margin given potenti favor reimburs
environ reduct tax given attract
growth compani busi believ humana
return signific return sharehold whether
organ mean takeout result
maintain outperform rate
healthcar legisl news develop
medicar advantag polici reimburs news
healthcar legisl neg impact
reimburs news wors expect
price target base combin two methodolog dcf valuat base beta termin
growth rate wacc estim ebitda price-to-earnings target repres
cash ep estim line five-year averag govern manag care group
reimburs polici gener half annual premium medicar advantag government-reimburs
program subject risk
regulatori risk insur larg regul across variou busi line includ state-bas feder oversight
extent law chang legisl process scrutini caus chang busi practic result
could impact
trend earn power quit sensit chang cost trend
total sell gener administra
depreci amort
incom tax
net incom report
dilut ep report
compani report oppenheim co inc
total sell gener administr
depreci amort
incom tax
net incom report
dilut ep report
sell gener administr
depreci amort
invest incom
incom tax
net incom report
ep result restat retroact
